Tissue-Specific Estrogen Action Novel Mechanisms, Novel Ligands, Novel Therapies /
Nuclear hormone receptors are not only important drug targets, but have also been the focus of decades of active and highly insightful research. Ten years ago, a review on nuclear receptors was entitled “The Second Decade” and a special issue of Molecular Endocrinology in 2005 dealt with the results...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2007.
|
Σειρά: | Ernst Schering Foundation Symposium Proceedings,
2006/1 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Interfering with the Dynamics of Estrogen Receptor-Regulated Transcription
- Actions of Estrogen and Estrogen Receptors in Nonclassical Target Tissues
- Genetic Dissection of Estrogen Receptor Signaling In Vivo
- Of Mice and Men: The Many Guises of Estrogens
- Estradiol Action in Atherosclerosis and Reendothelialization
- Functional Effects and Molecular Mechanisms of Subtype-Selective ER? and ER? Agonists in the Cardiovascular System
- Pathogenesis and Therapy of Rheumatoid Arthritis
- The Role of ER? and ER? in theProstate: Insights from Genetic Models and Isoform-Selective Ligands
- Preclinical Characterization of Selective Estrogen Receptor ? Agonists: New Insights into Their Therapeutic Potential
- Exploiting Nongenomic Estrogen Receptor-Mediated Signaling for the Development of Pathway-Selective Estrogen Receptor Ligands.